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Neuroﬁbrillary tangle-bearing neurons, a pathological hallmark of Alzheimer’s disease, are mostly
devoid of normal microtubule (MT) structure and instead have paired helical ﬁlaments that are
composed of abnormal hyperphosphorylated tau. However, a causal relationship between tau phos-
phorylation and MT disruption has not been clariﬁed. To examine whether MT disruption induces
tau phosphorylation, stathmin, an MT-disrupting protein, was co-expressed with tau in COS-7 cells.
Stathmin expression induced apparent MT catastrophe and tau hyperphosphorylation at Thr-181,
Ser-202, Thr-205, and Thr-231 sites. In contrast, c-Jun N-terminal kinase activation, or phosphatase
inhibition, led to signiﬁcant tau phosphorylation without affecting MT structure. These ﬁndings sug-
gest that MT disruption induces subsequent tau phosphorylation.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Tubulin heterodimers, a- and b-tubulin, assemble into microtu-
bules (MTs), which are in a dynamic equilibrium with the non-
polymerized form. Filamentous structures provide intracellular
cytoskeleton in various cells and are especially enriched in neurons
[1–4]. The extent of MT assembly is regulated by many factors such
as temperature, protein-modiﬁcation of tubulin, small molecules
like taxol, and some MT-interacting proteins [5–7]. Because MTs
have signiﬁcant roles in a broad range of biological functions,
including shaping the neuronal structure and transporting intra-
cellular cargoes, it is reasonable to speculate that MT disruption,
if any, profoundly affects neuronal architecture and function
[8–11].
Tau proteins were identiﬁed as a factor promoting MT assembly
and stabilization. MT assemblies are thought to be negatively
regulated by tau phosphorylation [12,13]. To date, more than 40
serine (Ser) and threonine (Thr) residues have been identiﬁed aschemical Societies. Published by E
heimer’s disease; MT, micro-
K, c-Jun N-terminal kinase;
lar signal-regulated kinase
medium; FBS, fetal bovine
athology, Faculty of Life and
Miyakodani, Kyotanabe-shi,
iyasaka).possible phosphorylation sites on tau [14]. Although the biological
signiﬁcance of individual phosphorylation sites is not known, it has
been known that phosphorylation of Ser-262 (numbered according
to the 441-residue tau) has a profound effect on its interaction
with MTs [15].
Neuroﬁbrillary tangles (NFTs) are a major neuropathological
hallmark in brains affected by Alzheimer’s disease (AD) and related
diseases. The central nervous system diseases in which NFT forma-
tion is predominant are categorized as tauopathies. Because the
areas in the brain that form NFTs often exhibit neuronal loss, the
formation of these ﬁlamentous structures is assumed to be the cru-
cial event in neuronal degeneration [16]. Abnormally phosphory-
lated tau is a major component of NFTs [17–19], which raises a
possible link between phospho-tau accumulation and neurodegen-
eration and has led us to investigate their causal relationship. NFT-
bearing neurons often accompany loss of MTs and tubulin [20–22].
This inverse relation can be observed across various animal models
for tauopathy [23,24]. It remains unclear why MTs or tubulin are
lost in the affected neurons. MT loss has also been found even in
non-NFT-bearing neurons in the AD brain [22], suggesting that
MT loss may precede tau phosphorylation and accumulation in
brains affected by tauopathy. Therefore, we aimed to elucidate
the possible link between MT loss and phospho-tau accumulation.
The effects of drug-inducing MT depolymerization on expressed
tau have been studied [25], which showed that the tau was
dephosphorylated at speciﬁc sites. However, the impacts of cell-
intrinsic MT-disrupter on tau phosphorylation have never beenlsevier B.V. All rights reserved.
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tubulin sequestration and is ubiquitously expressed in many cell
types, including neurons [26,27]. Furthermore, SCG10, a neuron-
speciﬁc homolog of stathmin, is known to increase in the brains
of AD patients [28]. To study whether physiological MT disruption
affects tau phosphorylation, tau and stathmin were co-expressed
in COS-7 cells using adenovirus-mediated transfection.2. Materials and methods
2.1. Materials
Anti-stathmin antisera against N- and C-terminal positions,
STN1 (ASSDIQVKELEKRA) and STC1 (RKNKESKDPADETEAD) were
raised against synthetic peptides conjugated with KLH. The anti-
tau antibodies used were tau-c, which reacts with pan-tau [29];
AT270, AT8, and AT180, which react with phospho-Thr181, phos-
pho-Ser202 and -Thr205, and phospho-Thr231 and -Ser235,
respectively (Innogenetics, Gent, Belgium); PHF-1, which reacts
with phospho-Ser396 and -Ser404 (a generous gift from P. Davies)
[30]; and PS422 (BioSource International, Camarillo, CA). Anti-a-
tubulin (DM1A) and anti-acetylated-a-tubulin (6-11B1) were pur-
chased from Sigma (St. Louis, MO). Okadaic acid was purchased
from Roche Diagnostics (Basel, Switzerland).
2.2. DNA constructs and expression in COS cells
Generation of recombinant adenovirus was performed as previ-
ously described [29]. Brieﬂy, stathmin cDNA encoding amino acids
1–145 was ampliﬁed and inserted between the HindIII and XbaI
sites of the pFLAG-CMV2 vector. The FLAG tagged-stathmin open
reading frame was inserted into the pAxCAwt vector (Takara) atIn
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Fig. 1. Adenoviral induction of stathmin induces MT catastrophe in COS-7 cells. MT stabi
immunocytochemical procedures. (A) Three days after infection with AxCA-F-stathmin (
evaluated by STC1 (a). Free (b) and polymerized tubulin (c) were fractioned as described
DM1A. The lower panel shows quantitative analyses of free (closed) or polymerized (ope
(S.E.) for three independent experiments. (B) 50 MOI of AxCA-F-stathmin-infected COS
confocal laser scanning microscopy. It should be noted that the low level of stathmin
expression caused cell to shrink (arrowhead). These abnormal cells were not observed in
a–c, 100 lm; d–i, 25 lm.the SwaI site (designated pAxCA-F-stathmin) and the resulting cos-
mid was used to generate recombinant adenoviruses (designated
AxCA-F-stathmin) by the COS-TPC method following the manufac-
turer’s instructions. Adenoviruses containing cDNA of the longest
isoform of human brain tau (AxCA-Tau4RWT), LacZ (AxCAi-LacZ),
c-Jun N-terminal kinase (JNK) 3 (AxCA-JNK3), and D mitogen-acti-
vated protein kinase/extracellular signal-regulated kinase kinase
kinase (MEKK) (AxCA-DMEKK) were also used [29]. COS-7 cells
were maintained in Dulbecco’s modiﬁed eagle’s medium (DMEM)
containing 10% fetal bovine serum (FBS) in a 5% CO2/air chamber.
For adenoviral expression, COS-7 cells were cultured in a six-well
dish and exposed to recombinant viruses at various multiplicities
of infection (MOI) in DMEM containing 5% FBS.
2.3. Cell fraction and Western blotting
COS-7 cells were gently washed with phosphate buffered saline
3 days after infection and lysed in Laemmli’s sample buffer. Each of
the fractions having equal start-cell counts were separated by 8%
SDS–PAGE and electroblotted onto nylon membranes for immuno-
blot analyses as previously described [29]. MT-bound and -un-
bound tau were prepared as described previously [25]. Okadaic
acid was added 1 day after infection of AxCA-Tau4RWT, and cells
were lysed 24 h after treatment.
2.4. Immunocytochemistry
Cells were ﬁxed with 4% paraformaldehyde for 10 min and per-
meabilized by 0.5% Triton X-100, followed by incubation with pri-
mary antibodies. Bound antibodies were visualized with Alexa
dye-conjugated secondary antibodies (Molecular Probes) and ob-
served with a confocal laser scanning microscope (Radiance 2000
KR3; Bio-Rad).b c
e f
h i
lity of COS-7 cells infected with AxCA-F-stathmin was analyzed by biochemical and
St) or AxCAi-LacZ (LZ) cDNA at the indicated MOI, the total amount of stathmin was
in Section 2 and quantiﬁed by Western blotting using the anti-a-tubulin antibody,
n) tubulin in COS-7 cells. Each data point represents the means and standard error
-7 cells (a–f) were co-labeled with STC1 (green) and DM1A (red), and observed by
expression induced mild MT disruption (arrow); however, high levels of stathmin
AxCAi-LacZ-infected cells (g–i). Merged images are shown in c, f, and i. Scale bars:
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3.1. Overexpression of stathmin induces MT catastrophe in COS-7 cell
In native neuronal cells, >90% of tau is bound to MTs [31]. How-
ever, excess exogenous tau generated by conventional transfection
is not bound to MT (data not shown). To maintain the tau expres-
sion at relatively low levels and avoid undesired liberation of tau
from MTs, we used an adenoviral-mediated transfection system
in which about 80% of the expressed tau was held on MTs at ﬁve
MOI of AxCA-Tau4RWT (data not shown).
The stathmin family is expressed in a wide variety of cells,
including neurons. It binds to the ends of tubulin protoﬁlamenttau-c
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Fig. 2. Selective phosphorylation of tau induced by stathmin expression in MT-unbound
and the extent of tau phosphorylation was estimated by Western blotting using site-sp
AxCA-F-stathmin-infected cells at the indicated MOI were separated by SDS–PAGE, and
labeled by immunoblotting. (B) Quantitative analyses of tau phosphorylation in cells wi
intensities of the bands labeled with the indicated antibodies were normalized to t
experiments. Statistical signiﬁcance was evaluated using a Student’s t-test (*P < 0.05). (C)
infected cells were subjected to Western blotting with the indicated antibodies. (D) MT
remixed with cell lysate from naïve COS-7 cells, and fractioned according to MT binding.
The arrows and asterisks indicate slow migrating and faster migrating tau species, respand induces MT catastrophe and/or tubulin sequestration [32–
35]. In this study, we used stathmin to induce MT disruption in
cells, and evaluated the effect of MT destruction on tau phosphor-
ylation under physiological conditions. We ﬁrst examined the ef-
fects of stathmin on MT structure in COS-7 cells. Three days after
infection with AxCA-F-stathmin, FLAG-tagged stathmin expressed
in an MOI-dependent manner (Fig. 1A, a). Along with increasing
stathmin expression, the amount of polymerized tubulin decreased
and that of soluble-free tubulin increased (Fig. 1A, b and c). The
fraction of polymerized tubulin was greatly reduced in the cells in-
fected with 50 MOI of AxCA-F-stathmin (Fig. 1A). To morphologi-
cally investigate MT catastrophe, COS-7 cells infected with 50
MOI of AxCAi-LacZ or AxCA-F-stathmin were double-labeled with0 AT8 AT180
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fractions. COS-7 cells were co-infected with AxCA-Tau4RWT and AxCA-F-stathmin
eciﬁc anti-phosphotau antibodies. (A) Total cell lysates from AxCA-Tau4RWT- and
total (tau-c) and phosphorylated tau (AT270, AT8, AT180, PHF1, and PS422) were
th (closed) or without (open) 50 MOI of AxCA-F-stathmin infection are shown. The
hose of total tau (tau-c). Data represent the means ± S.E. for three independent
MT-unbound and MT-bound fractions from AxCA-Tau4RWT and AxCA-F-stathmin-
-free tau from AxCAi-LacZ (LZ)- or AxCA-F-stathmin (St) infected cells (input) was
Each fraction was subjected to Western blotting using tau-c and DM1A (a-tubulin).
ectively.
3230 T. Miyasaka et al. / FEBS Letters 584 (2010) 3227–3232anti-a-tubulin and anti-FLAG antibodies (Fig. 1B). Although the
expression levels were slightly variable among cells, about 90% of
the cells were labeled by the anti-FLAG antibody (data not shown).
Moderate levels of stathmin expression resulted in decreased a-
tubulin staining in COS-7 cells compared to naïve cells (Fig. 1B,
d–f). High stathmin expression induced irregularly shrunken-
shaped cells and destroyed MT structures in the cells (Fig. 1B, a–
f). This was not observed in AxCAi-LacZ-infected cells (Fig. 1B, g–i).
3.2. Co-expression of stathmin enhances phosphorylation of tau
associated with MT destruction
To examine the effects of stathmin on tau phosphorylation,
COS-7 cells were co-infected with AxCA-Tau4RWT plus AxCAi-LacZ
or AxCA-F-stathmin at different MOI, and the total cell lysates ob-
tained were subjected to Western blotting using various anti-tau
antibodies (Fig. 2A). Although the total amount of tau was not al-
tered, the extent of phosphorylation of tau labeled by AT270
(Thr-181), AT8 (Ser-202 and Thr-205), and AT180 (Thr-231) in-
creased along with increasing expression of stathmin in a MOI-
dependent manner. There was statistical signiﬁcance in the extent
of tau phosphorylation between 0 and 50 MOI of AxCA-F-stathmin
(Fig. 2B). The immunoreactivities with PHF-1 (phospho-Ser396 and
-Ser404) and PS422 (phospho-Ser422) tended to slightly (but not
signiﬁcantly) increase. Thus, stathmin expression induced a higher
extent of tau phosphorylation.
The ability of the MT-binding of tau in cells can be estimated by
the fraction of the lysates under the presence of taxol [25]. In this
procedure, MT-bound tau is co-fractioned into a pellet with taxol-
stabilized MT, but MT-unbound tau is recovered in the superna-
tant. The total lysates from tau- and stathmin-expressing COS-7
cells were further fractioned by MT binding, and the phosphoryla-
tion of tau was analyzed by Western blotting. Along with MT dis-
ruption, the amount of MT-unbound tau increased. As seen inGSK3β
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Fig. 3. Activation of JNK in stathmin-expressing cells. Effects of stathmin expression on
using speciﬁc antibodies labeled for the activated or inactivated form of each kinase. T
AxCA-F-stathmin at the indicated MOI, and subjected to Western blotting using antibod
p44), phospho-Thr202/Tyr204 (p-MAPK), total JNK (p46/p54), and phospho-Thr183/Tyr18
without (open) 50 MOI of AxCA-F-stathmin infection are shown. Data represent the me
using a Student’s t-test (*P < 0.05).Fig. 2C, the MT-unbound tau migrated more slowly than MT-bound
tau, indicating a higher phosphorylation of MT-unbound tau. This
result was further conﬁrmed by Western blotting using anti-phos-
pho-tau antibodies, which showed that the phosphorylated tau oc-
curred predominantly in the MT-unbound fraction (Fig. 2C).
One possible explanation for the predominance of tau in the
MT-unbound fraction would be that the stathmin causes tau to lib-
erate from MT via accelerating tau phosphorylation and reducing
its afﬁnity to MT. To determine whether tau was phosphorylated
after being liberated from MTs, MT-unbound fractions from cells
expressing AxCA-Tau4RWT plus AxCAi-LacZ or AxCA-F-stathmin
(input in Fig. 2D) were remixed with cell homogenates from naïve
COS-7 cells and subjected to the MT binding assay (Fig. 2D). If the
tau in the MT-unbound fraction from stathmin-expressing cells
were phosphorylated after being liberated from MTs, there would
still have been some less phosphorylated tau, which can bind on
taxol-stabilized MTs. Western blotting of total tau in the MT-un-
bound fraction from stathmin-expressing cells showed that soluble
tau largely consisted of slow-migrating species and additional fast-
migrating one. This ﬁnding suggested that a fraction of soluble tau
contains relatively less phosphorylated tau species. Predictably,
the slower migrating species did not bind to MTs, but the faster
migrating tau species were still able to bind to MTs (Fig. 2D). The
presence of tau having an MT-binding capacity in the MT-unbound
fraction suggests that the tau was phosphorylated after being lib-
erated from MT. Thus, stathmin expression induces tau liberation
and its subsequent phosphorylation in parallel with MT disruption.
3.3. Stathmin expression induces activation of JNK
To examine whether certain protein kinases were activated by
stathmin, total lysates from infected cells were subjected to
Western blotting using antibodies that distinguish activated and
inactivated forms of protein kinase (Fig. 3). Among the kinasesPY216 PS9
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the activity of GSK3b (A), MAPK (B), and JNK (C) were veriﬁed by Western blotting
otal lysates were prepared from COS-7 cells co-infected with AxCA-Tau4RWT and
ies for total GSK3, phospho-Tyr216 (PY216), phospho-Ser9 (PS9), total MAPK (p42/
5 (p-JNK). (D) Quantitative analyses of fold kinase activation in cells with (closed) or
ans ± S.E. for three independent experiments. Statistical signiﬁcance was evaluated
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Fig. 4. Overexpression of JNK or inhibition of phosphatases induces tau phosphor-
ylation but not MT disruption. (A) MT-unbound and -bound fractions from COS-7
cells co-infected with ﬁve MOI of AxCA-Tau4RWT and AxCAi-LacZ (110 MOI; a),
AxCA-Tau4RWT and AxCA-F-stathmin (50 MOI; b), or AxCA-Tau4RWT and AxCA-
JNK3 plus DMEKK (10 + 100 MOI; c) were subjected to Western blotting using
DM1A (anti-a-tubulin), tau-c, and AT8. (B) Tau-expressing COS-7 cells were treated
with or without 50 nM of okadaic acid and subjected to an MT-binding assay
combined with Western blotting.
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MAPK was left inactivated in the cells of the AxCA-F-stathmin
infection as compared to those of the AxCAi-LacZ infection. The
activity of glycogen synthase kinase 3 beta (GSK3b) was not altered
throughout the experiment.
3.4. Activation of kinases or phosphatase inhibition induces tau
phosphorylation but not MT disruption
The above data led us to presume that stathmin induces MT dis-
ruption and tau phosphorylation via JNK activation. To test this
assumption, MT binding assays were performed in COS-7 cells
expressing JNK3 and its activator DMEKK. As previously reported,
AxCA-JNK3 plus AxCA-DMEKK infection increased tau phosphory-
lation at the AT8 sites; however, MT catastrophe was not observed
(Fig. 4A). This result indicates that the activation of JNK can only
induce tau phosphorylation but not MT disruption, and raises the
idea that tau phosphorylation and MT disruption may be
dissociated.
The extent of tau phosphorylation is also negatively regulated
by phosphatases [36–39]. To probe whether the phosphatase inhi-
bition induces MT disruption via tau phosphorylation, tau-express-
ing cells were treated with okadaic acid, a protein phosphatase-1
and -2A inhibitor. Although a high dose (250 nM) of okadaic acid
induced both tau phosphorylation and MT disruption (data not
shown), 50 nM okadaic acid solely induced tau phosphorylation
without MT disassembly (Fig. 4B). Thus, enhanced tau phosphory-
lation by phosphatase inhibition cannot induce MT disruption. Ta-
ken together, our data indicate that tau phosphorylation is not
sufﬁcient for MT disruption.4. Discussion
To our knowledge, this is the ﬁrst report to demonstrate that
MT disruption can induce subsequent tau phosphorylation. The ex-
tent of phosphorylation in MT-unbound tau produced by stathmin
expression is higher than those of MT-bound tau. Given that JNK is
activated by stathmin expression, it is possible that tau proteins
were phosphorylated by JNK after being liberated from MTs. How-
ever, tau phosphorylation selectively occurred in the MT-unbound
fraction (Fig. 2C), suggesting that the phosphorylation state of tau
is more likely dependent on whether the expressed tau is bound
with MT and that MT-unbound tau is a preferential substrate for
kinases. Given that the stoichiometry of tubulin relative to tau is
far greater than in healthy neurons, the amount of MT-unbound
tau would be negligible under physiological conditions [31]. How-
ever, under abnormal conditions, such as the aberrant overproduc-
tion of tau and decreased expression or denaturation of tubulin,
MT-unbound tau might be generated and be immediately
hyperphosphorylated.
The effects of drug-induced MT disruption on tau phosphoryla-
tion have been reported previously; however, the results were in
conﬂict with the present study [25]. This discrepancy may depend
on MT-breaking-agents used in the study. Stathmin can seques-
trate tubulin dimer(s) after MT destruction, and soluble tubulin di-
mer(s) likely remain to be bound to stathmin [27]. Although the
physiological signiﬁcance of soluble tubulin dimer is not known,
it is conceivable that the numerous cellular factors can interact
with them. Formation of stable tubulin–stathmin complex may
interfere the interaction between tubulin dimers and such mole-
cules including kinases, phosphatases, and tau. This may be that
the concentrations of tubulin dimers were reduced similarly as in
the neurons affected by tauopathy. In contrast, a small compound
like nocodazole may not affect the binding between soluble tubu-
lin dimers and other factors, and induce an increment in the solu-
ble tubulin dimers. In this way, the amount of soluble tubulin
dimers available for interaction with other molecules would be
critical for tau phosphorylation.
In contrast to MT destruction inducing tau phosphorylation, MT
destruction was not induced by the activation of certain kinases or
by phosphatase inactivation, both of which can increase tau phos-
phorylation. Similar ﬁndings have been reported in anesthetized
mice [40]. Therefore, these results suggest that tau phosphoryla-
tion, which may lead to the liberation of tau from MTs, does not
have a profound effect on the stabilization of MTs, although the
long-term effects of tau phosphorylation on MTs are remain un-
known. Our results are also supported by recent ﬁndings that no
differences exist between wild type and pseudo-phosphorylated
tau in transgenic animals [41,42]. Taken together, tau phosphory-
lation alone may not be sufﬁcient to induce MTs destruction and
subsequent neurodegeneration.
This view can be readily applied to the pathogenesis of tauopa-
thy, because the MT structure always disappear in affected neurons
in the brains of AD patients [19,22]. Most neurons remain through-
out a human lifetime, and MT disruption that leads to MT loss and/
or tubulin degeneration can accidentally occur in aged neurons
[21,22,43]. Newly expressed tau, which cannot bind to MTs, is then
phosphorylated and accumulate in the neuronal cell body. If such
an abnormality would be sustained over a long period, the accu-
mulated tau may form NFT, which accompanies complete MT dis-
ruption as seen in brains affected by tauopathy. In fact, MT loss has
also been found in non-NFT-bearing neurons in the brains of AD
patients [22], and phosphorylated tau may gradually accumulate
in the neuronal cell body for months [44].
The mechanisms inducing MT disruption in aged neurons re-
main obscure. Tubulin is a very unstable protein and easily loses
3232 T. Miyasaka et al. / FEBS Letters 584 (2010) 3227–3232its potency at 37 C for GTP/GDP exchange without GTP and pro-
tein-stabilizing compounds that have multiple hydroxyl groups
[45]. Thus, it is possible that a reduced tubulin turnover rate
and/or the reduced expression of factors required for tubulin main-
tenance can decrease the amount of MTs or tubulin in normal
aging neurons [46]. Dysregulation of stathmin families could be
other possible causes of MT dysregulation in aged or diseased neu-
rons [28,47]. Furthermore, amyloid deposition, which is the other
pathological hallmark of AD, may also lead to MT destabilization
[48], suggesting that MT loss may be an intermediate between
amyloid beta deposition and NFT formation in AD.
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